MedPath

Management of deep decay and pain in teeth using a new bioceramic material

Recruiting
Conditions
Pulpitis,
Registration Number
CTRI/2021/06/033971
Lead Sponsor
Gaurav Kulkarni
Brief Summary

To evaluate the effect on the outcome of cariously exposed permanent posterior teeth treated with partial/complete pulpotomy using a bioceramic material. The novel (but commercially available) bioceramic material will be placed as the medicament over the amputated pulp stumps and a permanent, well-sealing restoration would be placed on top of it. The biological response would be assessed at fixed follow-up intervals where defined clinical and radiographic parameters will be assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
153
Inclusion Criteria
  1. Permanent mature posterior teeth with deep to extremely deep caries 2) Teeth that give positive response to pulp vitality testing 3) Teeth in which vitality is confirmed clinically on gaining access 4) Teeth with or without periapical rarefaction 5) Teeth with probing depth and mobility within normal limits 6) Patients that agree to participate in the study.
Exclusion Criteria

1)Teeth with immature apices 2) Teeth where caries does not result in pulp exposure 3) Teeth with extensive caries that are unrestorable 4) teeth with intraoral/extraoral swelling and/or associated sinus tract 5) teeth subjected to abnormal stresses 6) medically compromised patients, pregnant or lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Maintenance of normal pulp vitality and normal periapical tissues3 weeks, 6 months, 12 months, 24 months
Secondary Outcome Measures
NameTimeMethod
Formation of dentinal bridge as assessed radiographically6 months, 12 months, 18 months, and 24 months

Trial Locations

Locations (1)

Dept of Conservative Dentistry and Endodontics

🇮🇳

Thane, MAHARASHTRA, India

Dept of Conservative Dentistry and Endodontics
🇮🇳Thane, MAHARASHTRA, India
Dr Gaurav Kulkarni
Principal investigator
9769234101
drgauravkulkarni@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.